Systematic review demonstrates better outcomes with intravenous corticosteroids in Graves' ophthalmopathy, suggesting a need for further trials.
IV steroids were associated with more favourable outcomes and better tolerability than oral steroids in moderate-to-severe GO. Further comprehensive trials are needed to confirm long-term safety and optimize treatment protocols.
No takes yet. Share an insight, caveat, or question.
Almutairi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: